BR112019025019A2 - polipeptídeo isolado de pilus de clostridium perfringens, polipeptídeo imunogênico, vetor, vacina, uso de um polipeptídeo imunogênico, método de tratamento, anticorpo, método para detectar infecção e método para detectar um polipeptídeo imunogênico - Google Patents

polipeptídeo isolado de pilus de clostridium perfringens, polipeptídeo imunogênico, vetor, vacina, uso de um polipeptídeo imunogênico, método de tratamento, anticorpo, método para detectar infecção e método para detectar um polipeptídeo imunogênico Download PDF

Info

Publication number
BR112019025019A2
BR112019025019A2 BR112019025019-0A BR112019025019A BR112019025019A2 BR 112019025019 A2 BR112019025019 A2 BR 112019025019A2 BR 112019025019 A BR112019025019 A BR 112019025019A BR 112019025019 A2 BR112019025019 A2 BR 112019025019A2
Authority
BR
Brazil
Prior art keywords
polypeptide
pilus
seq
clostridium perfringens
fact
Prior art date
Application number
BR112019025019-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Jianhua Gong
Dion LEPP
Original Assignee
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food filed Critical Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food
Publication of BR112019025019A2 publication Critical patent/BR112019025019A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112019025019-0A 2017-05-31 2018-05-31 polipeptídeo isolado de pilus de clostridium perfringens, polipeptídeo imunogênico, vetor, vacina, uso de um polipeptídeo imunogênico, método de tratamento, anticorpo, método para detectar infecção e método para detectar um polipeptídeo imunogênico BR112019025019A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762513001P 2017-05-31 2017-05-31
US62/513001 2017-05-31
PCT/CA2018/050643 WO2018218360A1 (en) 2017-05-31 2018-05-31 Vaccine against necrotic enteritis in poultry

Publications (1)

Publication Number Publication Date
BR112019025019A2 true BR112019025019A2 (pt) 2020-06-30

Family

ID=64454163

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019025019-0A BR112019025019A2 (pt) 2017-05-31 2018-05-31 polipeptídeo isolado de pilus de clostridium perfringens, polipeptídeo imunogênico, vetor, vacina, uso de um polipeptídeo imunogênico, método de tratamento, anticorpo, método para detectar infecção e método para detectar um polipeptídeo imunogênico

Country Status (8)

Country Link
US (2) US11318194B2 (https=)
EP (1) EP3630800A4 (https=)
JP (2) JP2020527051A (https=)
CN (1) CN110691787A (https=)
BR (1) BR112019025019A2 (https=)
CA (1) CA3064461A1 (https=)
MX (1) MX2019014450A (https=)
WO (1) WO2018218360A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234130A (zh) * 2021-05-24 2021-08-10 安徽医科大学第四附属医院 一种卡氏肺孢子菌重组蛋白及其制备方法与应用
WO2025199604A1 (en) * 2024-03-27 2025-10-02 Université de Montréal Recombinant vaccine proteins for the prevention of avian necrotic enteritis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958962A3 (en) * 1997-06-12 2013-05-01 Novartis International Pharmaceutical Ltd. Artificial antibody polypeptides
AU6094000A (en) * 1999-07-13 2001-01-30 Med Immune, Inc. Donor strand complemented pilin and adhesin broad-based vaccines
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
WO2007116322A2 (en) * 2006-02-17 2007-10-18 Novartis Ag Purification of bacterial antigens
US7745175B2 (en) * 2006-10-27 2010-06-29 Dow Agrosciences Llc Polynucleotides encoding Clostridium perfringens alpha toxin proteins
US20100062025A1 (en) * 2006-11-20 2010-03-11 Intervet International B.V. Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine
US20110097360A1 (en) * 2007-05-25 2011-04-28 Claudio Donati Streptococcus pneumoniae pilus antigens
PL2164862T3 (pl) * 2007-06-08 2015-12-31 Australian Poultry Crc Pty Ltd Toksyna netb z clostridium
EP2162150A4 (en) * 2007-06-22 2011-10-12 Univ Guelph VACCINE AGAINST CLOSTRIDIUM PERFRINGENS
WO2011113801A1 (en) * 2010-03-16 2011-09-22 Universiteit Gent Use of clostridium perfringens strain 23 to protect against necrotic enteritis
AR099470A1 (es) * 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
FR3065623B1 (fr) * 2017-04-28 2021-07-09 Roquette Freres Albumines de pois ameliorees, procede d'obtention et leurs applications
MX2021000184A (es) * 2018-07-05 2021-05-12 Novobind Livestock Therapeutics Inc Anticuerpos contra agentes patogenos en aves de corral y sus aplicaciones.

Also Published As

Publication number Publication date
JP2023090702A (ja) 2023-06-29
RU2019137515A3 (https=) 2021-12-03
EP3630800A1 (en) 2020-04-08
CA3064461A1 (en) 2018-12-06
US11318194B2 (en) 2022-05-03
US20200093913A1 (en) 2020-03-26
MX2019014450A (es) 2020-02-10
EP3630800A4 (en) 2021-03-24
CN110691787A (zh) 2020-01-14
WO2018218360A1 (en) 2018-12-06
US20220226455A1 (en) 2022-07-21
JP2020527051A (ja) 2020-09-03
RU2019137515A (ru) 2021-06-30

Similar Documents

Publication Publication Date Title
JP2009077713A (ja) アイメリア・マキシマ（Ｅｉｍｅｒｉａｍａｘｉｍａ）の配偶子母細胞由来の組換え５６及び８２ｋＤａ各抗原をコードする核酸及びその使用
KR102071743B1 (ko) 신규의 약독화된 시겔라 생백신
MX2012014395A (es) Vacuna y metodos para reducir una infeccion por campylobacter.
US20220226455A1 (en) Vaccine against necrotic enteritis in poultry
EP2532363B1 (en) Use of flagellins from the genus marinobacter as vaccination adjuvants
JP3037359B2 (ja) コクシジウム症ワクチン
JP4160640B2 (ja) クラミジア・ニューモニエ由来の表面露出タンパク質
JPH04504656A (ja) ボルデテラワクチン
US20120269842A1 (en) Enterotoxigenic e. coli fusion protein vaccines
AU2010234193B2 (en) Methods and compositions for treating and preventing Shiga toxin-producing Escherichia coli infection
ES2358804T3 (es) Polipéptidos de campylobacter jejuni ubicados en superficie.
EP2888365A1 (en) A novel toxin in type a clostridium perfringens
CN107446872A (zh) 一种组成型表达兔病毒性出血症病毒vp60蛋白的重组乳酸菌疫苗株及其制备方法和用途
NZ540485A (en) M. haemolytica outer membrane protein PlpE as a vaccine or vaccine component against shipping fever
RU2788096C2 (ru) Вакцина против некротического энтерита у домашней птицы
BR112021000312A2 (pt) Vacina, peptídeos, polipeptídeo, polinucleotídeo, vetor de vacina, método de tratamento ou prevenção da infecção por map ou da condição ou sintoma associado à infecção por map e kit
CN105198982A (zh) 基于il-6的抗原表位及其应用
HK40019772A (en) Vaccine against necrotic enteritis in poultry
KR20120054465A (ko) 소 코로나바이러스 항원 결정기를 포함하는 스파이크 재조합 단백질 및 이에 대한 항체
WO2010059899A2 (en) Vaccine for runting-stunting syndrome
US10987414B2 (en) Adhesin tip multiepitope fusion antigen platform and vaccines and their use in the treatment of enterotoxigenic diarrhea
WO2024086846A1 (en) Methods and compositions for immunizing against campylobactor hepaticus
PL201982B1 (pl) Przeciwciała poliklonalne przeciwko białkom Helicobacter pylori oraz sposób ich wytwarzania
CN116640191A (zh) 副猪嗜血杆菌Omp P2蛋白基因I型和II型的通用性B细胞线性表位及其应用
JP2001321183A (ja) ペプチドリピート免疫原

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements